THE CHANGES IN THE SYNTHESIS OF PROTEINS OF PREGNANCY IN SOME CLINICAL MANIFESTATIONS OF UTEROPLACENTAL INSUFFICIENCY

I.P. Pavlov Russian Medical Biological Herald ›› 2012, Vol. 20 ›› Issue (3) : 27 -32.

PDF
I.P. Pavlov Russian Medical Biological Herald ›› 2012, Vol. 20 ›› Issue (3) :27 -32. DOI: 10.17816/PAVLOVJ2012327-32
Articles
research-article

THE CHANGES IN THE SYNTHESIS OF PROTEINS OF PREGNANCY IN SOME CLINICAL MANIFESTATIONS OF UTEROPLACENTAL INSUFFICIENCY

Author information +
History +
PDF

Abstract

Miscarriage and fetal growth retardation which cause alterations in the protein synthesis function of the uteroplacental complex occupy one of the leading positions in the structure of causes of perinatal and child morbidity and mortality. Investigation of the dynamics of TBG, AMGF, PAMG levels during treatment of uteroplacental insufficiency was conducted. The changes revealed in the protein synthesis indicate dysaptation, which is more evident if there is fetal growth retardation than if there is threatened miscarriage.

Keywords

pregnancy / uterine-placental insufficiency / fetal growth retardation syndrome

Cite this article

Download citation ▾
null. THE CHANGES IN THE SYNTHESIS OF PROTEINS OF PREGNANCY IN SOME CLINICAL MANIFESTATIONS OF UTEROPLACENTAL INSUFFICIENCY. I.P. Pavlov Russian Medical Biological Herald, 2012, 20(3): 27-32 DOI:10.17816/PAVLOVJ2012327-32

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Гончарова С.В. Особенности формирования репродуктивного потенциала у девочек-подростков, родившихся с задержкой внутриутробного развития / С.В. Гончарова, Н.В. Башмакова // Материалы IX Всероссийского форума «Мать и дитя» (2-5 октября 2007 г.). - М., 2007. - С. 651-652.

[2]

Кулаков В.И. Плацентарная недостаточность и инфекция. Руководство для врачей / В.И. Кулаков, Н.В. Орджоникидзе, В.Л. Тютюнник. - М., 2004. - 494 с.

[3]

Сидельникова В.М. Привычная потеря беременности / В.М. Сидельникова. - М.: Триада-Х, 2002. - 304 с.

[4]

Сидорова И.С. Клинико-диагностические аспекты фетоплацентарной недостаточности / И.С. Сидорова, И.О. Макаров. - М.: Медицинское информационное агентство, 2005. - 296 с.

[5]

Ergaz Z. Intrauterine growth restrictionetiology and consequences: what do we know about the human situation and experimental animal models? / Z. Ergaz, M. Avgil, A. Ornoy // Reproductive Toxicology. - 2005. - Vol. 20. - P. 301-322.

[6]

Hui L. Diagnosis and management of fetal growth restriction: the role of fetal therapy / L. Hui, D. Challis // Best Practice & Research Clinical Obstetrics & Gynaecology. - 2008. - Vol. 22. - P. 139-158.

[7]

Maternal risk factors for abnormal placen tal growth: the national collaborative per inatal project / K. Baptiste-Roberts [et al.] // BMC Pregnancy and Childbirth. - 2008. - Vol. 23. - P. 44.

[8]

Neerhof M.G. The fetal response to chron ic placental insufficiency / M.G. Neerhof, L.G. Thaete // Seminars in Perinatology. - 2008. - Vol. 32. - P. 201-205.

[9]

Neonatal and pregnancy outcome in primary antiphospholipid syndrome: a 10-year experience in one medical center / A.K. Chou [et al.] // Pediatrics and Neonatology. - 2009. - Vol. 50. - P. 143-146.

RIGHTS & PERMISSIONS

Chikin V.G., Pchelintsev V.V.

PDF

156

Accesses

0

Citation

Detail

Sections
Recommended

/